Sirolimus Vs. Prednisone As Initial Systemic Therapy for Minnesota Standard Risk (MN-SR), Ann Arbor 1/2 Acute Graft-Vs-Host Disease (GVHD): Primary Results of the Multi-Center Randomized Phase II BMT CTN 1501 Trial
Sign Up to like & getrecommendations! Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.128
Abstract: Clinical- and biomarker-based stratification tools may identify a lower risk acute GVHD population amenable to novel, reduced intensity treatments. Previous retrospective data suggest sirolimus, a steroid-free primary therapy, may rival standard of care prednisone. We… read more here.
Keywords: prednisone; sirolimus prednisone; risk; day ... See more keywords